Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
  • A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
  • A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
  • A61F2/06—Blood vessels
  • A61F2/064—Blood vessels with special features to facilitate anastomotic coupling
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
  • A61F2/2493—Transmyocardial revascularisation [TMR] devices
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
  • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
  • A61B2017/00238—Type of minimally invasive operation
  • A61B2017/00243—Type of minimally invasive operation cardiac
  • A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
  • A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
  • A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
  • A61B2017/1107—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
  • A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
  • A61B2017/1135—End-to-side connections, e.g. T- or Y-connections

Definitions

• the present invention relates generally to fluid shunting and perfusion, and more particularly to an apparatus and method for bypassing a restricted blood vessel segment using a relatively elongated, rigid shunt implant.
• Coronary artery disease is a major problem in the U.S. and throughout the world. In fact, about 1.1 million "open heart” procedures are performed each year, and current estimates are that approximately 4.8 million people suffer from some degree of congestive heart failure.
• one or more arterial or venous segments are harvested from the body and then surgically inserted between the aorta and the coronary artery.
• the inserted vessel segments, or transplants act as a bypass of the blocked portion of the coronary artery and thus provide for a free or unobstructed flow of blood to the heart. More than 500,000 bypass procedures are performed in the US every year.
• Coronary artery bypass grafting has been used for more than 30 years. Initially, the saphenous vein (SV) served as the principal conduit for coronary bypass, but studies over the last dozen years have shown a 35-40% increase in 10-year patency rate for the internal thoracic artery (ITA) compared with the SV. The SV, in fact, has only been shown to have a 10-year patency rate of 50%. Since the mid 1980's, not only the ITA, but also the alternative arterial conduits have been increasingly used. These conduits include the gastroepiploic artery (GEA), inferior epigastric artery (IEA), and radial artery (RA), which have been used primarily as supplements to both the right and left ITA.
• GAA gastroepiploic artery
• IVA inferior epigastric artery
• RA radial artery
• arterial conduits results in demonstrably better long-term patency
• use of arteries in place of the SV often requires complex technical challenges, such as free grafts, sequential anastomosis, and conduit-to-conduit anastomosis.
• Some of the reasons for the difficulty in using arterial conduits reside in the fact that they are much more fragile than the SV and therefore easier to damage, and due to their smaller size, easier to occlude completely or partially through technical error during grafting.
• Such coronary artery bypass surgery is a very intrusive procedure that is expensive, time-consuming and traumatic to the patient.
• the operation requires an incision through the patient's sternum (sternotomy), and that the patient be placed on a bypass pump so that the heart can be operated on while not beating.
• a vein graft is harvested from the patient's leg, another highly invasive procedure, and a delicate surgical procedure is required to piece the bypass graft to the coronary artery (anastomosis). Hospital stays subsequent to the surgery and convalescence periods are prolonged.
• PTC A percutaneous transluminal coronary angioplasty
• other types of angioplasty are not always indicated due to the type or location of the blockage, or due to the risk of emboli formation.
• Wilk U.S. 5,409,019 and 5,429,144.
• These Wilk references teach a minimally-invasive method of transluminal catheter delivery of a collapsed stent, which is subsequently introduced through the myocardial wall from an adjacent coronary artery and expanded to provide a bypass shunt between the left ventrical and the adjacent coronary artery.
• This prior art technique teaches the delivery of a transmyocardial bypass shunt in a collapsed, reduced-profile configuration, which requires radial expansion subsequent to delivery in a bore pre-formed in the myocardial wall.
• the bore is formed, for example, by a drill, needle, Seldinger wire, dilating wires or catheters, or other devices prior to stent placement and expansion.
• the present invention is directed to a system and method for providing a perfusion, reperfusion or bypass system that can be delivered in a minimally invasive procedure which avoids the sternotomy and other intrusive procedures normally associated with coronary bypass surgery. It also frees the physician from the multiple anastomoses necessary in the current process.
• the system can be implemented in a minimally invasive manner. Alternatively, it may also provide for temporary blood flow through the coronary artery during the anastomosis procedure.
• a shunt is used to direct blood directly from the left ventricle of the heart to the coronary artery at a point distal to the blockage.
• the shunt comprises a rigid, generally elongated stent in the form of a single spike having an opening at either end, and adapted to be positioned in the myocardium.
• the coronary artery, the myocardium and the wall of the left ventricle of the heart are pierced by the spike from an outside space or tissue in a transverse manner to provide a channel completely through from the coronary artery to the left ventricle of the heart.
• An opening located on the distal end of the spike is positioned within the left ventricle.
• An opening on the proximal end of the spike is positioned in the coronary artery.
• Oxygenated blood is pumped from the left ventricle, through the distal opening, through the hollow central portion of the spike, out of the proximal opening and into the coronary artery distal to the blockage.
• the spike is anchored in the myocardium to provide a permanent passage for blood to flow between the left ventricle of the heart and the coronary artery, distal to the blockage.
• the spike can be used temporarily to maintain blood flow through the coronary artery during therapeutic procedures, such as coronary bypass.
• the spike can be used to deliver a vein graft, and to provide for the passage of blood around the blockage until the anastomosis of the graft is complete.
• a first combination access and shunt device is used to direct the blood from the coronary artery proximal to the stenosis.
• a second access and shunt device is located in the vessel distal of the stenosis to receive the diverted blood and allow it to continue on its course downstream.
• the combination access/shunt device comprises a spike element for providing access to the vessel and anchoring the system in place. The spike pierces the artery from the outside and travels completely through it and into the myocardium or other heart tissue adjacent the coronary artery.
• the spike has a spike or barb or series of barbs on its distal end and is otherwise designed so that it has substantial resistance to pull back or exit from the vessel.
• the spike pierces through the vessel from an outside space or tissue in a transverse manner.
• a shunt device mounted on top of the spike is a shunt device that comprises an aperture and a diversion conduit. With the spike in its anchoring position, the shunt device is located partially in the vessel and partially outside of the vessel from the direction in which the spike entered. The aperture resides in the vessel to allow blood to enter therein and subsequently travel to the diversion tube, which is in fluid communication with the aperture. This provides the shunting of blood into the diversion tube of the combination access/shunt device.
• a connector piece which mates with a bypass conduit.
• These elements are also in fluid communication to allow the blood to bypass the blockage and to be shunted to a location distal thereof.
• another similar combination access/shunt device can be placed to allow the shunted blood to re-enter the artery in a free-graft configuration, and continue on its path downstream.
• a single device can be used distal of the restriction and connected to an appropriate graft for revascularization.
• the apparatus of the present invention is preferably implanted in a minimally invasive manner using thoroscopy or another endoscopic procedure.
• thoroscopy or another endoscopic procedure.
• open surgery or other means of vascular access are also possible.
• the apparatus can be implanted permanently, or can be used temporarily to provide a bypass system during various surgical procedures, including coronary bypass procedures.
• the apparatus of the present invention can advantageously be implanted in a minimally invasive manner using thoroscopy or other endoscopic procedure.
• thoroscopy or other endoscopic procedure.
• open surgery or other vascular access is also possible.
• FIG. 1 is a small-scale cross-sectional view of a heart with a blockage in the coronary artery, illustrating one embodiment of the bypass device of the present invention
• FIG. 2 is a close-up perspective view of a first embodiment of the device of FIG. 1 invention shown implanted in the myocardium, with the coronary artery, myocardium and left ventricle of the heart shown cut-away;
• FIGs. 3A-C illustrate a method for implanting the device of FIG. 1;
• FIGs. 4A-B illustrate an alternate method for implanting the device of FIG. 1;
• FIGs. 5A-B illustrate the temporary use of the stent during a coronary bypass procedure
• FIG. 6 is a small scale cross-sectional view of a heart with a blockage in the coronary artery, and further illustrating a second embodiment of the bypass device of the present invention
• FIG. 7 is a close-up cross-sectional view of the blockage in the coronary artery and illustrating in greater detail a second embodiment of the spiked bypass device of FIG. 6;
• FIG. 8 is a perspective view of the spiked bypass device and conduit according to a second embodiment of the present invention.
• FIG. 9 is a close-up view of a third embodiment of the present invention formed of a single shunt device having a spiked distal tip;
• FIG. 10 is a perspective view of a fourth embodiment of the present invention, formed of a shunt device having a spike on its distal end;
• FIG. 1 1 is a perspective view of a shunt device according to a fifth embodiment of the present invention.
• FIG. 12 is a perspective view of a shunt device according to a sixth embodiment of the present invention.
• FIG. 13 is a perspective view of a shunt device according to a seventh embodiment of the present invention.
• FIG. 14 is a perspective view of a shunt device according to a eighth embodiment of the present invention.
• FIG. 15 is a perspective view of a shunt device according to a ninth embodiment of the present invention.
• FIG. 16 is a close-up cross-sectional view of a coronary artery blockage and the shunt device according to FIG. 14;
• FIG. 17 is a close-up cross-sectional view of a coronary artery blockage and the myocardium of a patient and the shunt device according to FIG. 14;
• FIG. 18 is a perspective view of a shunt device according to a tenth embodiment of the present invention.
• FIG. 19 is a perspective view of a shunt device according to a eleventh embodiment of the present invention.
• FIG. 20 is a perspective view of a shunt device according to a twelfth embodiment of the present invention
• FIG. 21 is a perspective view of a shunt device according to a thirteenth embodiment of the present invention.
• FIG. 22 is a close-up cross-sectional view of a coronary artery and the myocardium of a patient and the shunt device according to FIG. 19;
• FIG. 23 is a close-up cross-sectional view of a coronary artery of a patient and the shunt device according to FIG. 21.
• the coronary artery branches off the aorta and is positioned along the external surface of the heart wall. Oxygenated blood flows from the heart to the aorta, into the coronary artery, and on to the rest of the body. In some individuals, plaque builds up within the coronary artery, blocking the free flow of blood and causing complications ranging from mild angina to heart attack and death.
• the present invention provides for the shunting of blood to a site in the coronary artery, which is distal to the blockage.
• a single hollow spike is inserted through the walls of the coronary artery and the myocardium and into the left ventricle of the heart, which lies beneath the coronary artery.
• the hollow spike is positioned such that the openings on either end of the spike are within the coronary artery and the left ventricle. Blood flows through the opening in the left ventricle, through the hollow spike and out of the opening positioned in the coronary artery distal to the site of the blockage.
• FIG. 1 there is shown a cross-sectional view of a typical heart, aorta AO, and the coronary artery CA having a blockage BL therein.
• the coronary artery CA lies along the external surface of the wall of the heart MYO.
• the coronary artery CA supplie s oxygenated blood pumped from the left ventricle of the heart LV and through the aorta
• FIG. 1 also illustrates in schematic fashion one embodiment of the bypass device 10 of the present invention implanted distal to the blockage BL in the coronary artery CA.
• the present invention can be used to treat arteries and vessels other than the coronary artery.
• other types of blockages or vascular defects can be treated, including, for example, vascular bypass in other areas to alleviate problems such as aneurysms, deep vein thrombosis, or other types of calcified or stenosed vessels.
• the current device may be used to bypass obstructed bile ducts in the liver, or to direct the blood supply away from tumors in an effort to destroy them. Access devices using configurations other than spiked may also be implemented. Thus, the following description should not be construed to be limiting in any way.
• FIG. 2 there is shown in greater detail one preferred embodiment of the bypass apparatus 10 of the present invention.
• the apparatus 10 is preferably formed of a biocompatible material, such as metal or a polymer.
• the apparatus 10 is shown piercing the coronary artery CA distal to the site of the blockage BL.
• the details of this spiked device 10 are described below.
• the device 10 pierces completely through the coronary artery CA, with the central portion of the device 12 positioned within the myocardium MYO and the distal portion of the device 14 implanted in the left ventricle of the heart LV.
• Each shunt device 10 (FIG. 2) is comprised of a central portion formed by a hollow lumen 12 having an aperture or opening on each end 16, 18.
• One opening 16 receives blood from the left ventricle LV and shunts it through the hollow lumen 12 and out the other opening 18 which is positioned in the coronary artery CA.
• the spike 10 therefore allows oxygenated blood to flow directly from the left ventricle LV and into the coronary artery CA, as indicated by the arrows in FIG. 2.
• the distal end of the spike 14 may be blunt (FIG. 4B) or tapered if desired (FIG. 2) to aid in the insertion of the device 10 through the coronary artery CA, the heart wall MYO and the left ventricle LV.
• the proximal end of the spike 20 is preferably provided with a head portion 22 that is larger than the diameter of the lumen (FIG. 2), to help anchor the spike 10 in place and prevent it from migrating or passing completely through the coronary artery CA.
• This head portion 22 also acts to seal the puncture in the coronary artery CA formed by the distal tip of the spike 14. The blood therefore flows through the spike 10 and downstream within the coronary artery CA, and not outwardly through the puncture opening. If desired, this portion of the device
• the device 22 may be sutured into the surrounding tissue to prevent the device 10 from migrating from its proper position. Additional anchoring in the form of sutures or other means 24 is also preferably provided along the central portion of the spike 12. Anchoring the device 12 into the myocardium MYO prevents migration of the spike 10 from its proper position.
• the spike 12 may also include a second opening 25 at its proximal end 20 opposite from the first opening 18. This second opening 25 allows for the perfusion of blood from the coronary artery CA as shown by the arrow in Figure 2.
• the physician would make a small incision of a keyhole type in order to gain access to the blocked vessel. Vision could be obtained through thoroscopy or similar endoscopic procedure. Such access would be very minimally invasive.
• the spike is implanted the body in the manner described above.
• the spiked device would preferably be introduced by way of an automatic gun or needle in order to reduce procedure times and avoid bleeding.
• the spike could be implanted in other ways as well.
• FIGs. 3A-C One method for implanting the device is illustrated in FIGs. 3A-C.
• the spike 30 is first mounted over a needle 32 (FIG. 3A), and the needle 32 is used to puncture the coronary artery CA, myocardium MYO and left ventricle LV (FIG. 3B).
• the needle 32 is then removed (FIG. 3C) and the anterior hole in the coronary artery CA is closed using sutures 34 or other suitable methods.
• a flap FL is first cut in the wall of the coronary artery CA and the needle 32 bearing the spike 30 is inserted through the flap FL and through the other side of the coronary artery CA, through the myocardium MYO, and into the left ventricle LV.
• the needle 32 is withdrawn, leaving the spike 30 in place.
• the flap FL is then closed using sutures 34 or other suitable means.
• the spike 30 is preferably anchored in place in the myocardium MYO as described above to prevent migration and to ensure that the free flow of blood from the left ventricle LV to the coronary artery CA is maintained.
• the spike 30 can be used to provide temporary blood flow during therapeutic procedures.
• a section of vein VG taken from the leg of the patient is attached at one end to the aorta AO and at the other end to a point distal to the blockage in the coronary artery CA.
• This surgery requires the delicate procedure of joining the vein graft VG to the aorta AO and to the coronary artery CA.
• This joining of the blood vessels is known as anastomosis.
• the patient is placed on a heart-lung machine to keep the blood oxygenated and flowing during this procedure, and the blood is diverted from the coronary artery CA to allow the physician to complete the anastomosis.
• the spike 30 is used to maintain blood flow through the coronary artery CA during bypass surgery (FIG. 5A).
• the vein graft VG is loaded on top of the stent 30 prior to implantation.
• the spike 30 is implanted as described above, at the point of the vein graft VG anastomosis.
• the vein graft VG is sutured to the aorta and to the CA at a point distal to the blockage BL. If desired, the sutures can be preloaded onto the graft VG to facilitate the anastomosis.
• the spike 30 is removed, and blood flow occurs from the aorta AO. through the vein graft VG, and down the coronary artery CA.
• the spike 30 can be sutured in place during the anastomosis procedure for permanent attachment, if desired.
• FIG. 6 illustrates in schematic fashion another embodiment of the bypass device 110 of the present invention.
• This embodiment is mounted both proximally and distally of the blockage BL by means of spiked combination access/shunt devices 112 and bypass conduit 114, described in more detail below.
• FIG. 6 there is shown a cross-sectional view of a typical heart anatomy including the aorta AO with a blockage BL or stenosis in the coronary artery CA, which is positioned along the external surface of the heart wall HW.
• the coronary artery supplies blood pumped from the left ventricle LV to the aorta AO and into the heart muscles or myocardium MYO.
• bypass device 110 of the present invention mounted both proximally and distally of the blockage BL by means of spiked combination access/shunt devices 112 and bypass conduit 114, described in more detail below.
• spiked combination access/shunt devices 112 and bypass conduit 114 described in more detail below.
• vascular bypass in other areas to alleviate problems such as aneurysms, deep vein thrombosis, or other types of calcified or stenosed vessels.
• the current system may be used to bypass obstructed bile ducts in the liver, or to direct the blood supply away from tumors in an effort to destroy them.
• Access devices using configurations other than spiked can also be implemented and bypass conduits can be integrated, attachable, or of other configurations.
• the term "vessel” shall be deemed to embrace any body organ, vessel, space or vasculature, including artificial members or prior implants, which contains or can contain bodily fluid. Thus, the following description should not be construed to be limiting in any way.
• FIG. 7 there is shown in greater detail one preferred embodiment of the bypass apparatus 110 of the present invention.
• the apparatus 110 is preferably formed of a biocompatible material, such as metal or a polymer.
• a pair of combination access/shunt devices 1 12 is shown proximally and distally of the blockage BL. The details of these spiked devices 1 12 are described below and shown in connection with FIGs. 9 and 10.
• each access/shunt device 112 pierces completely through the coronary artery CA on the outside, leaving the spiked portion 116 of the device 112 implanted in the wall of the heart wall HW.
• the spiked portion 116 provides not only piercing action through the coronary artery CA, but also into the tissue to provide anchoring and stabilization of the artery.
• the spiked portion 116 can be embedded in a tissue or passed completely through the tissue and into the left ventricle LV as shown in the distal device.
• Each access/shunt device 112 (FIG. 9) is comprised of a shunt portion 118 having an aperture 120 which, in the case of the proximal device, receives blood from the coronary artery CA and shunts it into a diversion tube 122 mounted proximally with respect to the spiked portion 116 and the aperture 120.
• the diversion tube 122 is in fluid communication with the aperture 120 to allow blood flow from the coronary artery CA into the aperture 120 and into the diversion tube 122 as indicated by the arrows in FIG. 7.
• Mounted proximally with respect to the diversion tube 122 is a connector piece 124, which is also in fluid communication therewith.
• the combination access/shunt device 112 which is distal of the blockage BL may be constructed in a similar fashion or may have another configuration in which blood flows in the opposite direction as indicated by the arrows in FIG. 7.
• a bypass conduit 114 (FIG. 8), which is hollow, is mounted on the two connector portions 124 of the devices 112, as shown in FIG. 7, to allow blood to bypass the blockage BL.
• the conduit 114 may be constructed from a vein or artery graft taken from the patient or a donor, an artificial vein graft, or any other biocompatible tubing including one made from a metal or polymer. All these connections are fluid-tight, as described below in more detail, to avoid hemorrhaging.
• FIG. 7 illustrates the conduit portion 114 somewhat exploded away from the connector portions 124 in order to illustrate the manner in which the complete bypass system can be assembled.
• FIG. 8 illustrates the conduit portion 114 of the bypass system 110 completely press-fit or snapped-down over the connector portions 124 (not shown), as will be the case in the final installation of the system.
• FIG. 9 illustrates the combination access/shunt device 112 in greater detail.
• the distal spike portion 116 as described above, provides access to the coronary artery C A by piercing completely therethrough and into the surrounding tissue.
• the barbed distal portion 126 having one or more barbs provides anchoring for the entire device.
• the proximal shunt portion 118 which resides in the vessel comprises an aperture 120 to allow blood to flow therein and from there, at a right angle, into the diversion tube 122 mounted proximally with respect to the aperture 120, as indicated by the arrow in FIG. 9.
• the proximal shunt portion 118 may be tapered if desired to aid in the insertion of the device 112 through the coronary artery CA and into the heart wall.
• a connector tube 124 for receiving the bypass conduit 114 as described above.
• the connector tube 124 is frusto-conical in order to provide a fluid-tight press-fit for the bypass.
• a biocompatible fabric or mesh (not shown) is incorporated into the structure of the device. This fabric or mesh helps to seal the vessel to prevent bleeding and provides a structure that allows endothelial cells to infiltrate the device 112 and incorporate it into the surrounding tissues.
• FIG. 9 illustrates an inverted U-shaped saddle portion 128 of the device 112, which serves a dual purpose.
• This saddle portion 128 fits over the artery when the combination access/shunt device 110 is installed therein, thereby stabilizing the artery.
• this saddle device 128 acts as a flange for self-sealing the puncture in the coronary artery CA formed by the barbed distal tip 126.
• blood flows through the diversion tube 122, and not outwardly through the puncture opening.
• a loop may be added the saddle portion 128 to allow the device to be sutured into the myocardium to prevent the device from migrating from its proper position.
• FIG. 10 is an alternative embodiment of the spiked access/shunt device of FIG. 9 in which a planar flange 130 serves to stabilize the artery and to self-seal the puncture therein.
• FIGs. 11, 12 and 13 show additional views of three of the embodiments for device 112.
• FIG. 11 shows device 112 having a rounded configuration.
• FIG. 12 shows device 112 having a tapered configuration to aid in the insertion of the device 112.
• FIG. 13 shows device 112 having a collar or saddle 132 to help contain the artery may help with any possible migration problems.
• the physician would make a small incision of a keyhole type in order to gain access to the blocked vessel. Vision could be obtained through thoroscopy or similar endoscopic procedure. Such access would be very minimally invasive.
• the combination access/shunt devices 112 are installed in the artery in the manner described above.
• the spiked devices would preferably be introduced by way of an automatic gun that would implant both spiked devices 112 and the conduit 114 at the same time in order to reduce procedure time and avoid bleeding. Alternatively, the spikes could be introduced individually, provided that bleeding is controlled.
• the device can be sutured in place to provide for permanent bypass; alternatively, the device can be implanted temporarily to maintain the flow of blood through the coronary artery during bypass surgery.
• the device is implanted as described above.
• a vein graft is sutured in place, with one end anastomosed to the aorta, and the other end to the coronary artery at a site distal to the blockage.
• the device provides blood flow from the aorta to the coronary artery at a site distal to the blockage during the anastomosis.
• the bypass device of the present invention may be removed.
• FIG. 14 illustrates a further embodiment of the combination access/shunt device 212.
• the distal spike portion 216 as described above, provides access to the coronary artery by piercing completely therethrough and into the surrounding tissue.
• the barbed distal portion 226 having one or more barbs provides anchoring for the entire device.
• the proximal shunt portion 218 which resides in the vessel comprises an aperture 220 to allow blood to flow therein and from there, at a right angle, into the diversion tube 222 mounted proximally with respect to the aperture 220.
• the proximal shunt portion 218 may be tapered if desired to aid in the insertion of the device 212 through the coronary artery and into the heart wall.
• a connector tube 224 for receiving a bypass conduit as described above.
• the connector tube 224 can be frusto-conical in order to provide a fluid-tight press-fit for the bypass.
• a biocompatible fabric or mesh (not shown) is incorporated into the structure of the device. This fabric or mesh helps to seal the vessel to prevent bleeding and provides a structure that allows endothelial cells to infiltrate the device 212 and incorporate it into the surrounding tissues.
• a planar flange 230 serves to stabilize the artery and to self-seal the puncture therein.
• FIG. 15 illustrates a further embodiment of the combination access/shunt device 312.
• the distal spike portion 316 as similar to that described above with respect to other embodiments, and has a barbed distal portion 326 having one or more barbs for anchoring the device.
• the proximal shunt portion 318 which resides in the vessel comprises an aperture 320 to allow blood to flow into the diversion tube 322.
• the proximal shunt portion 318 may be tapered.
• the top of the diversion tube 322 forms a tapered connector portion 324 for receiving a bypass conduit as described above. It will be noted that the connector portion 324 can be frusto- conical.
• a biocompatible fabric or mesh (not shown) is incorporated into the structure of the device, as above.
• a planar flange 330 serves to stabilize the artery and to self-seal the puncture therein.
• Attached to the planar flange an distributed thereabout are at least one retaining members 323, which can comprise detents at the end thereof for engaging the bypass conduit.
• the detents can be in the form of hooks, clasps, split rings, pads, or the like in order to mechanically retain the bypass conduit onto the connector portion 324 of the diversion tube 322.
• FIG. 16 the shunt device 212 of FIG. 14 is depicted in cross-section, where like features are referred to by the same reference numerals.
• the view depicts the device 212 inserted into an artery, such as the coronary artery CA of a patient, and further depicts a blockage BL therein.
• a bypass conduit, for example a vein or artery graft, 214 is secured to the connector tube 224 of the diversion tube 222 above the flange 230.
• an access port or hole may be placed along the shunt body opposite the aperture 220 at portion 232 to increase total flow and to maintain blood perfusion through the vessel bypassed.
• FIG. 17 presents a view similar to that of FIG. 16, showing the barb 226 of the spike device implanted in the myocardium MYO of a patient for perfusing the coronary artery CA.
• a side-by-side bypass device 412 is depicted in FIG. 18.
• the distal spike portion 416 is similar to that described above with respect to other embodiments, and has a barbed distal portion 426 having one or more barbs for anchoring the device.
• the proximal shunt portion 418 which resides in a vessel comprises an aperture 420 to allow blood to flow into the diversion tube 422.
• the aperture 420 passes through the shunt portion 418, and allows communication with the diversion tube to either side of the shunt portion 418.
• the proximal shunt portion 418 may be tapered.
• the top of the diversion tube 422 forms a connector portion with a second aperture 421 for communicating with a bypass conduit, such as an artery or vein graft.
• a biocompatible fabric or mesh (not shown) can be incorporated into the structure of the device.
• a planar flange 430 serves to stabilize the artery and to self-seal the puncture therein.
• a flange 434 is provided at the end of the diversion tube 422 to self- seal the puncture in the artery or vein graft.
• FIG. 19 depicts an alternative embodiment 412' similar to the device of FIG. 18.
• the device of FIG. 19 has an aperture 420', which extends through only one side of the shunt portion 418'.
• the apertures of this and the preceeding embodiment may be selectively placed and sized according to the desired application, the orientation of the blood vessels employed, and the location of anatomical features, blockages, etc.
• FIG. 20 depicts a further alternative embodiment 412" that is similar to the embodiment depicted in FIGs. 18 and 19 except that there is no flange between the apertures 420 and 421 , but rather a smooth transition area 430".
• the shunt body 418" is shown to have a gentle taper.
• FIG. 21 A further, "rivet" type embodiment 512 is depicted in FIG. 21.
• the hollow shunt body 518 is held into the wall of a vessel by one or more retention members 540, which are deployed after introduction. This embodiment will be further discussed with reference to FIG. 23.
• FIG. 22 is a cutaway schematic representation of the shunt device 412' depicted in FIG. 19 mounted within the patient, with the spiked end resident within the myocardium MYO.
• the coronary artery CA and the bypass graft 414 are shown to be placed in fluid communication by the apertures 420', 421 in the shunt 412'.
• this illustration is illustrative of all side-by- side instant anastomosis devices described herein.
• a hole may be located at position 436 to allow additional perfusion of the coronary artery CA, and that the aperture 420' could pass through both sides, as in devices 412 and 412".
• the device could be mounted at an angle, as discussed hereinabove.
• FIG. 23 is a cutaway schematic representation of the "rivet" type shunt device 512 depicted in FIG. 21 mounted within the patient, with the retention members 540 deployed.
• a flange 534 seals the incision and maintains a bearing surface against the bypass graft 514, which could be veinous or arterial.
• An aperture 520 opens a channel into the hollow stent body 518, which terminates in an open end 542.
• the open end 542 is resident within the coronary artery CA.
• the "rivet" type device advantageously provides a low profile, with the least amount of material in the vasculature and none in the myocardium.
• an anastomosis shunt device of the type depicted in FIG. 14 can be dimensioned to have a height of 12.5 mm, with a body width of about 2 mm, a flange diameter of about 2.8 mm, and an inside diameter of the diversion tube of about 1.4 mm.
• the spike can be dimensioned to be about 3 mm in height tapering to a width of about 2.1 mm.
• the aperture can be dimensioned to be about 1.4 mm in diameter, and can have an edge radius about the periphery of about 0.10 mm all around.
• An anastomosis shunt device of the type depicted in FIG. 18 can be dimensioned to have a height of 12.65 mm, with a body width of about 2.8 mm, a flange diameter of about 3.4 mm, and an inside diameter of the diversion tube of about 2.0 mm.
• the spike can be dimensioned to be about 3 mm in height tapering to a width of about 2.6 mm.
• the apertures can be dimensioned to be about 2.0 mm in diameter, and can have an edge radius about the periphery of about 0.10 mm all around.
• the present bypass device and method provide significant improvements in present treatment of vascular blockages. It should be understood that while various anatomical features have been discussed herein for ease of reference, other uses of the instant anastomosis devices described herein are foreseen, and the disclosure should not be interpreted as limited strictly to use with the coronary artery, etc. It is intended that the present invention is applicable to a wide range of uses where vascular anastomosis is indicated. It is further intended that the present invention may applicable during a wide variety of surgical techniques, from conventional sternotomy or "open chest” procedures, to minimally-invasive direct coronary artery bypass (MIDCAB) approaches.
• MIDCAB minimally-invasive direct coronary artery bypass

Applications Claiming Priority (5)

Publications (1)

Family

ID=26796382

Family Applications (1)

Country Status (4)

Families Citing this family (14)

Family Cites Families (12)

• 1999
  • 1999-02-17 EP EP99939805A patent/EP1121166A2/de not_active Withdrawn
  • 1999-02-17 AU AU32994/99A patent/AU3299499A/en not_active Abandoned
  • 1999-02-17 JP JP2000569859A patent/JP2003534822A/ja active Pending
  • 1999-02-17 WO PCT/US1999/003484 patent/WO2000015275A2/en not_active Application Discontinuation

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events